Table 4 Regression analyses of neonatal outcomes in untreated groups compared to controls or the treated groups
Untreated IADPSG | Untreated NICE | ||||
|---|---|---|---|---|---|
Comparison | Controls | Treated IADPSG | Controls | Treated NICE | |
Composite adverse neonatal outcome | Unadjusted OR | 1.10 (0.80–1.50) | 0.39 (0.28–0.53) | 1.35 (0.83–2.19) | 0.37 (0.23–0.62) |
Model I | 1.07 (0.77–1.48) | 0.39 (0.28–0.54) | 1.26 (0.75–2.09) | 0.35 (0.20–0.60) | |
Model II | 1.01 (0.71–1.44) | 0.38 (0.27–0.53) | 1.05 (0.60–1.85) | 0.32 (0.18–0.57) | |
Hypoglycaemia | Unadjusted OR | 1.38 (0.81–2.36) | 0.20 (0.12–0.34) | 1.50 (0.64–3.50) | 0.18 (0.08–0.41) |
Model I | 1.32 (0.76–2.31) | 0.20 (0.12–0.33) | 1.59 (0.68–3.76) | 0.21 (0.09–0.49) | |
Model II | 1.24 (0.70–2.20) | 0.19 (0.11–0.33) | 1.34 (0.55–3.28) | 0.21 (0.09–0.49) | |
Hyperbilirubinaemia | Unadjusted OR | 1.12 (0.76–1.65) | 0.74 (0.49–1.11) | 0.95 (0.48–1.90) | 0.51 (0.25–1.03) |
Model I | 1.11 (0.75–1.67) | 0.75 (0.49–1.14) | 0.87 (0.42–1.81) | 0.44 (0.20–0.95) | |
Model II | 1.04 (0.67–1.63) | 0.79 (0.51–1.23) | 0.61 (0.26–1.40) | 0.41 (0.17–0.98) | |
Perinatal mortality | Unadjusted OR | 1.0 (0.12–8.26) | 0.51 (0.06–4.35) | 6.15 (1.23–30.7) | 1.85 (0.34–10.00) |
Model I | - | 4.02 (0.44–36.4) | 1.05 (0.10–11.11) | ||
Model II | - | 3.69 (0.24–57.9) | - | ||
Birth trauma | Unadjusted OR | 0.61 (0.22–1.71) | 0.41 (0.16–1.41) | 1.41 (0.43–4.62) | 0.85 (0.24–3.03) |
Model I | 0.58 (0.20–1.65) | 0.46 (0.16–1.37) | 1.46 (0.44–4.83) | 0.86 (0.17–2.27) | |
Model II | 0.57 (0.20–1.63) | 0.45 (0.15–1.37) | 1.51 (0.46–5.02) | 0.65 (0.17–2.44) | |